Kitov Pharma Ltd. Warrants
KTOVW
KTOVW was delisted on the 23rd of November, 2020.
5 hedge funds and large institutions have $167K invested in Kitov Pharma Ltd. Warrants in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
25% more funds holding
Funds holding: 4 → 5 (+1)
84% less capital invested
Capital invested by funds: $1.04M → $167K (-$877K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$12K |
| 2 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$11.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$944K |
| 2 |
ICM
Ionic Capital Management
New York
|
-$6.8K |
KTOVW Hedge Fund Activity: Q3 2016 in Review
5 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Kitov Pharma Ltd. Warrants (KTOVW) for Q3 2016, worth a combined $167K — down 84% from $1.04M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new KTOVW positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $12K. The largest seller was Sabby Management, exiting entirely with an estimated $944K sold.
- 5 institutional investors held Kitov Pharma Ltd. Warrants (KTOVW) as of Q3 2016, up from 4 in Q2 2016.
- Funds reported $167K of Kitov Pharma Ltd. Warrants stock for Q3 2016, down 84% quarter-over-quarter.
- 2 funds opened new Kitov Pharma Ltd. Warrants positions in Q3 2016 and 1 closed out, a net change of +1 holder.
- The largest Kitov Pharma Ltd. Warrants buyer in Q3 2016 was Virtu KCG Holdings, an estimated $12K added.
- The largest Kitov Pharma Ltd. Warrants seller in Q3 2016 was Sabby Management, an estimated $944K sold.
Based on aggregated 13F filings for Q3 2016.